BioNTech will wind up its vaccine manufacturing plant in Singapore by February 2027 after a strategic review. Read more at ...
The Cool Down on MSN
Pfizer seeks FDA approval for new Lyme disease vaccine candidate
Vector-borne and tick-borne infections like Lyme disease have been rising sharply in recent years. Pfizer seeks FDA approval for new Lyme disease vaccine candidate first appeared on The Cool Down.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results